{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:14:26Z","timestamp":1743066866284,"version":"3.40.3"},"publisher-location":"Cham","reference-count":41,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031568251"},{"type":"electronic","value":"9783031568268"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-56826-8_4","type":"book-chapter","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T05:01:44Z","timestamp":1712034104000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the COVID-19 Vaccine Distribution in Germany"],"prefix":"10.1007","author":[{"given":"Tamina","family":"Katerbau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Steenbock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8973-7847","authenticated-orcid":false,"given":"Herbert","family":"Kotzab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"137935","DOI":"10.1016\/j.jclepro.2023.137935","volume":"417","author":"S Abbasi","year":"2023","unstructured":"Abbasi, S., Zahmatkesh, S., Bokhari, A., Hajiaghaei-Keshteli, M.: Designing a vaccine supply chain network considering environmental aspects. J. Clean. Prod. 417, 137935 (2023)","journal-title":"J. Clean. Prod."},{"issue":"1","key":"4_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-022-01729-x","volume":"21","author":"M Bayati","year":"2022","unstructured":"Bayati, M., Noroozi, R., Ghanbari-Jahromi, M., Jalali, F.S.: Inequality in the distribution of covid-19 vaccine: a systematic review. Int. J. Equity Health 21(1), 1\u20139 (2022)","journal-title":"Int. J. Equity Health"},{"key":"4_CR3","unstructured":"RND: Ein Jahr Corona in Deutschland: Erster Fall am 27. Januar 2020 bei Webasto in Bayern gemeldet. https:\/\/www.rnd.de\/gesundheit\/ein-jahr-corona-in-deutschland-erster-fall-am-27-januar-2020-bei-webasto-in-bayern-gemeldet-LH7QYMIXZNQBM5I4AYK56KVYCU.html (2020). Accessed 26 Aug 2023"},{"key":"4_CR4","unstructured":"Dunkel, M.: Impfstoff-Logistik: \u201eDeutschland ist sehr gut vorbereitet\u201d (2020). https:\/\/www.capital.de\/wirtschaft-politik\/impfstoff-logistik-deutschland-ist-sehr-gut-vorbereitet. Accessed 31 Aug 2023"},{"key":"4_CR5","unstructured":"DW: Germany begins rollout of Moderna vaccine \u2013 DW \u2013 01\/12\/2021 (2023a). https:\/\/www.dw.com\/en\/coronavirus-germany-rolls-out-moderna-vaccine\/a-56205028. Accessed 26 Aug 2023"},{"key":"4_CR6","unstructured":"DW (2023b) Germany distributes COVID-19 vaccine to states \u2013 DW \u2013 12\/26\/2020. https:\/\/www.dw.com\/en\/germany-distributes-covid-19-vaccine-to-states-ahead-of-rollout\/a-56061628. Accessed 26 Aug 2023"},{"key":"4_CR7","first-page":"200","volume":"2","author":"M Egger","year":"2018","unstructured":"Egger, M.: Aktuelle Entwicklungen und Herausforderungen in der Arzneimitteldistribution. Pharmind 2, 200 (2018)","journal-title":"Pharmind"},{"key":"4_CR8","unstructured":"EMA: Good distribution practice. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/compliance\/good-distribution-practice (2023)"},{"issue":"1","key":"4_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40545-022-00411-5","volume":"15","author":"ML Fahrni","year":"2022","unstructured":"Fahrni, M.L., et al.: Management of COVID-19 vaccines cold chain logistics: a scoping review. J. Pharm. Policy Pract. 15(1), 16 (2022)","journal-title":"J. Pharm. Policy Pract."},{"key":"4_CR10","unstructured":"G\u00f6belbecker, J.: Wie werden Covid-19-Impfstoffe verpackt? (2021). https:\/\/www.pharma-food.de\/ausruestung\/verpacken-kennzeichnen\/wie-werden-covid-19-impfstoffe-verpackt-277.html. Accessed 26 Aug 2023"},{"key":"4_CR11","unstructured":"Good Manufacturing Practice (GMP) (2023). https:\/\/www.gmp-verlag.de\/content\/de\/gmp-informationen\/was-ist-gmp#:~:text=GMP%20(%22Good%20Manufacturing%20Practice%22,die%20Gute%20Herstellungspraxis%20f%C3%BCr%20Arzneimittel.&text=GMP%20stellt%20sicher%2C%20dass%20Patient,Lagerung%20von%20Arzneimitteln%20erf%C3%BCllt%20werden"},{"key":"4_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-24367-7","volume-title":"Comprehensive Logistics","author":"T Gudehus","year":"2012","unstructured":"Gudehus, T., Kotzab, H.: Comprehensive Logistics. Springer Berlin Heidelberg, Berlin, Heidelberg (2012). https:\/\/doi.org\/10.1007\/978-3-642-24367-7"},{"key":"4_CR13","unstructured":"Hohmann-Jeddi, C.: Pl\u00e4ne des BMG: Wann kommen die Covid-19-Impfstoffe in die Lieferkette? (2021) https:\/\/www.pharmazeutische-zeitung.de\/wann-kommen-die-covid-19-impfstoffe-in-die-lieferkette-123722\/. Accessed 30 Aug 2023"},{"key":"4_CR14","unstructured":"H\u00fctten, F.: Impfstoffverteilung: Die gro\u00dfe Herausforderung (2021). https:\/\/www.dvz.de\/dossiers\/impfstoff-logistik\/detail\/news\/impfstoffverteilung-die-grosse-herausforderung.html. Accessed 30 Aug 2023"},{"key":"4_CR15","unstructured":"IATA: CEIV Pharma (2023). https:\/\/www.iata.org\/en\/services\/certification\/special-cargo\/ceiv-pharma\/. Accessed 4 Nov 2023"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2008-2231-21-69","volume":"21","author":"M Jaberidoost","year":"2013","unstructured":"Jaberidoost, M., Nikfar, S., Abdollahiasl, A., Dinarvand, R.: Pharmaceutical supply chain risks: a systematic review. DARU J. Pharm. Sci. 21, 1\u20137 (2013)","journal-title":"DARU J. Pharm. Sci."},{"key":"4_CR17","unstructured":"J\u00fcngst, I.: Impfstoffverteilung in Deutschland: Logistik unter Aufsicht. https:\/\/www.eurotransport.de\/artikel\/impfstoffverteilung-logistik-unter-aufsicht-11176962.html (2021). Accessed 26 Aug 2023"},{"key":"4_CR18","doi-asserted-by":"crossref","unstructured":"Khan, D., Hashmani, M.A., Jung, L.T., Junejo, A.Z.: Blockchain enabled track-and-trace framework for covid-19 immunity certificate. In: 2022 2nd International Conference on Computing and Information Technology (ICCIT), pp. 248\u2013253 (2022)","DOI":"10.1109\/ICCIT52419.2022.9711597"},{"issue":"3","key":"4_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1504\/IJLSM.2019.103085","volume":"34","author":"S Khoukhi","year":"2019","unstructured":"Khoukhi, S., Bojji, C., Bensouda, Y.: A review of medical distribution logistics in pharmaceutical supply chain. Int. J. Logistics Syst. Manag. 34(3), 297\u2013326 (2019)","journal-title":"Int. J. Logistics Syst. Manag."},{"key":"4_CR20","unstructured":"Knight, B.: COVID vaccine \u2013 who should be first? \u2013 DW \u2013 12\/18\/2020 (2020). https:\/\/www.dw.com\/en\/covid-german-regulations-on-who-gets-vaccine-first\/a-55987647. Accessed 26 Aug 2023"},{"key":"4_CR21","first-page":"3","volume":"22","author":"A Kossik","year":"2022","unstructured":"Kossik, A.: Unser Ziel ist 100-prozentige Transparenz in der Lieferkette. Verkehr 22, 3 (2022)","journal-title":"Verkehr"},{"key":"4_CR22","unstructured":"Kuhlmann, S., Franzke, J., Dumas, B.P., Heuberger, M.: Regierungs-und Verwaltungshandeln in der Coronakrise: Fallstudie Deutschland. Universit\u00e4tsverlag Potsdam (2023)"},{"key":"4_CR23","unstructured":"K\u00fcmmerlen, R.: Massive Kritik an Verteilung von Impfstoffen (2021a). https:\/\/www.dvz.de\/rubriken\/logistik\/industrie-und-handelslogistik\/detail\/news\/deutliche-kritik-an-impfstofflogistik.html. Accessed 30 Aug 2023"},{"key":"4_CR24","unstructured":"K\u00fcmmerlen, R.: Erfolg braucht gutes Zeitmanagement (2021b). https:\/\/www.dvz.de\/rubriken\/meinung\/detail\/news\/erfolg-braucht-gutes-zeitmanagement.html. Accessed 30 Aug 2023"},{"key":"4_CR25","unstructured":"K\u00fcmmerlen, R.: Krisenstab soll Impfstofflogistik reorganisieren (2021c). https:\/\/www.dvz.de\/dossiers\/impfstoff-logistik\/detail\/news\/bund-schreibt-impfstofflogistik-aus.html. Accessed 26 Aug 2023"},{"key":"4_CR26","unstructured":"Kurz, C.: Impfstart in Hausarztpraxen: Lieferungen von Covid-19-Impfstoffen in Apotheken laufen gut an (2021). https:\/\/www.pharmazeutische-zeitung.de\/lieferungen-von-covid-19-impfstoffen-in-apotheken-laufen-gut-an-124860\/. Accessed 30 Aug 2023"},{"key":"4_CR27","unstructured":"M\u00fcller, C.: Wer darf wo bestellen \u2013 und wann? (2021). https:\/\/www.deutsche-apotheker-zeitung.de\/news\/artikel\/2021\/09\/17\/wer-darf-wo-bestellen-und-wann. Accessed 30 Aug 2023"},{"key":"4_CR28","unstructured":"PEI: Saisonale Influenza-Impfstoffe. https:\/\/www.pei.de\/DE\/arzneimittel\/impfstoffe\/influenza-grippe\/influenza-node.html (2022a). Accessed 30 Aug 2023"},{"key":"4_CR29","unstructured":"PEI: COVID-19-Impfstoffe. https:\/\/www.pei.de\/DE\/arzneimittel\/impfstoffe\/covid-19\/covid-19-node.html (2022b). Accessed Aug 30 2023"},{"key":"4_CR30","doi-asserted-by":"crossref","unstructured":"Peralvo, F.C., Vanegas, P.C., Avila-Ord\u00f3\u00f1ez, E.: A systematic review of COVID-19 transport policies and mitigation strategies around the globe. Transportation Research Interdisciplinary Perspectives, 100653 (2022)","DOI":"10.1016\/j.trip.2022.100653"},{"key":"4_CR31","unstructured":"Preu\u00df, F., Patermann, S., Uebelacker, T.: Vorbild Biontech: Das sind Deutschlands innovativste Mittelst\u00e4ndler (2021). https:\/\/www.wiwo.de\/unternehmen\/mittelstand\/vorbild-biontech-das-sind-deutschlands-innovativste-mittelstaendler\/27422392.html. Accessed 30 Aug 2023"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-4614-1734-7_10","volume-title":"Handbook of Healthcare System Scheduling","author":"MD Rossetti","year":"2012","unstructured":"Rossetti, M.D., Buyurgan, N., Pohl, E.: Medical supply logistics. In: Hall, R. (ed.) Handbook of Healthcare System Scheduling, pp. 245\u2013280. Springer US, Boston, MA (2012). https:\/\/doi.org\/10.1007\/978-1-4614-1734-7_10"},{"key":"4_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-658-15264-2","volume-title":"Pharmalogistik: Prozesse\u2013Instrumente-Praxisbeispiele","author":"CW Stoller","year":"2017","unstructured":"Stoller, C.W.: Pharmalogistik: Prozesse\u2013Instrumente-Praxisbeispiele. Springer (2017)"},{"key":"4_CR34","unstructured":"Sullivan, C.: Schneller impfen durch effiziente Logistik (2021). https:\/\/www.dvz.de\/dossiers\/impfstoff-logistik\/detail\/news\/schneller-impfen-durch-effiziente-logistik.html. Accessed 26 Aug 2023"},{"key":"4_CR35","unstructured":"Tiga: What Serialization Means for Pharma Manufacturing (2023). https:\/\/www.tigahealth.com\/what-serialization-means-for-pharma-manufacturing\/. Accessed 26 Aug 2023"},{"key":"4_CR36","unstructured":"VR: Das gro\u00dfe Impfen (2021). https:\/\/www.verkehrsrundschau.de\/nachrichten\/transport-logistik\/das-grosse-impfen-2841855. Accessed 26 Aug 2023"},{"issue":"9","key":"4_CR37","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1080\/13669877.2021.2001674","volume":"25","author":"GW Warren","year":"2022","unstructured":"Warren, G.W., Lofstedt, R.: COVID-19 vaccine rollout management and communication in Europe: one year on. J. Risk Res. 25(9), 1098\u20131117 (2022)","journal-title":"J. Risk Res."},{"key":"4_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-658-36302-4","volume-title":"Globale Pharmaindustrie \u2013 quo vadis?: Daten, Hintergr\u00fcnde und Analysen \u2013 eine Branchenbewertung","author":"G Watzek","year":"2022","unstructured":"Watzek, G.: Globale Pharmaindustrie \u2013 quo vadis?: Daten, Hintergr\u00fcnde und Analysen \u2013 eine Branchenbewertung. Springer Fachmedien Wiesbaden, Wiesbaden (2022). https:\/\/doi.org\/10.1007\/978-3-658-36302-4"},{"key":"4_CR39","unstructured":"WHO: Coronavirus disease (COVID-19) pandemic (2023a). https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019. Accessed 26 Aug 2023"},{"key":"4_CR40","unstructured":"WHO: Germany (2023b). https:\/\/www.who.int\/countries\/deu. Accessed 26 Aug 2023"},{"key":"4_CR41","unstructured":"WHO: WHO Coronavirus Disease (COVID-19) Dashboard with vaccination data (2023c). https:\/\/covid19.who.int. Accessed 26 Aug 2023"}],"container-title":["Lecture Notes in Logistics","Dynamics in Logistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-56826-8_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T05:03:32Z","timestamp":1712034212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-56826-8_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031568251","9783031568268"],"references-count":41,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-56826-8_4","relation":{},"ISSN":["2194-8917","2194-8925"],"issn-type":[{"type":"print","value":"2194-8917"},{"type":"electronic","value":"2194-8925"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"3 April 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"LDIC","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on Dynamics in Logistics","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Bremen","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Germany","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2024","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"14 February 2024","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"16 February 2024","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"ldic2024","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/www.uni-bremen.de\/ldic-conference\/about-ldic","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}